2025
SJR Q1
JCR Q3 · 2,7
OA
2 matched articles
SCIE
Journal detail
Therapeutic Advances in Chronic Disease
- Publisher
- SAGE Publications Inc.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
2040622320406231
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,937
- Quartile Q1
- H-Index 59
- Cites/doc 2,95
- Docs (3y) 243
- Cites (3y) 833
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,7
- 5Y JIF 3,5
- JCI 0,65
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q1
Areas
- Medicine
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q3 | 0,937 | 2,7 | 3,5 | 0,65 | Q2 | 59 |
| 2024 | Q1 | Q2 | 0,966 | 2,8 | 3,4 | 0,72 | Q2 | 54 |
| 2023 | Q1 | Q2 | 1,031 | 3,3 | 3,8 | 0,84 | Q2 | 54 |
| 2022 | Q1 | Q2 | 0,975 | 3,5 | 4,2 | 0,86 | Q2 | 54 |
| 2021 | Q1 | Q2 | 1,019 | 5 | 5,4 | 0,89 | Q2 | 54 |
| 2020 | Q1 | Q1 | 1,027 | 5,1 | 5,6 | 0,86 | Q2 | 54 |
| 2019 | Q1 | Q1 | 1,384 | 4,3 | — | 0,97 | Q2 | 54 |
| 2018 | — | Q1 | — | 4,5 | — | 0,9 | Q2 | — |
| 2017 | Q1 | Q1 | 1,895 | 4,9 | — | 1,01 | Q1 | 54 |
| 2016 | Q1 | — | 1,266 | — | — | — | — | 54 |
| 2015 | Q1 | — | 0,922 | — | — | — | — | 54 |
| 2014 | Q2 | — | 0,638 | — | — | — | — | 54 |
| 2013 | Q3 | — | 0,3 | — | — | — | — | 54 |
| 2012 | Q3 | — | 0,219 | — | — | — | — | 54 |
| 2011 | Q3 | — | 0,167 | — | — | — | — | 54 |
| 2010 | — | — | — | — | — | — | — | 54 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 191/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 157/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 119/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 120/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 80/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 61/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 51/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 36/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 20/261 |